Leading Wall Street analysts are not entirely convinced about Palantir's (PLTR) future. This can be determined simply by looking at each analyst's opinions. While several have raised their price targets, others, such as Goldman Sachs and Morgan Stanley, have recommended selling, citing the company's overvaluation.

This occurs despite the company's positive quarterly results, and despite the fact that it has raised its full-year outlook. Similarly, the Denver-based firm's stock opened with a sharp 10% drop, later extending its loss margin to -13.6%.

Despite the plunge, Palantir stock still boasts a gain of more than 40% so far in 2025.

Wall Street Weighs in on Palantir's Future

Goldman Sachs: Maintains neutral rating and raises price target from $80 to $90, suggesting a steep downside of more than 25%.

Morgan Stanley: Raised its price target from $90 to $98. This translates to a potential downside of 20% by Monday's close.

Deutsche Bank: While it sharply raised its price target from $50 to $80, the firm rated Palantir as a sell, expecting a drop of more than 35%.

Loop Capital: Maintains its buy rating, raising its price target from $125 to $130, indicating a potential upside of 5%.

Wedbush: Raised its price target from $120 to $140, one of the highest in the market. Dan Ives expects the stock to rise at least 13%.